Frederick P Michael, DO | |
19251 Mack Ave, Grosse Pointe Woods, MI 48236-2893 | |
(313) 343-3749 | |
(313) 343-7921 |
Full Name | Frederick P Michael |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 19251 Mack Ave, Grosse Pointe Woods, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255324802 | NPI | - | NPPES |
3368642 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 5101008128 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Frederick P Michael, DO 19251 Mack Ave, Grosse Pointe Woods, MI 48236-2893 Ph: (313) 343-7280 | Frederick P Michael, DO 19251 Mack Ave, Grosse Pointe Woods, MI 48236-2893 Ph: (313) 343-3749 |
News Archive
Nancy Delano, 80, of Denver has no plans to slow down anytime soon. She still drives to movies, plays and dinners out with friends. A retired elder care nurse who lives alone, she also knows that "when you reach a certain age, emergencies can happen fast." So, when her son, Tom Rogers, talked to her about installing a remote monitoring system, she didn't hesitate.
Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH). Nymox expects to report final results and statistical analysis for the study in the next 1-2 weeks. The new study concerns assessment of the 48-60 month efficacy and benefits of a single treatment of NX-1207.
Using immunotherapy biologic agents that stimulate the body's immune system pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous system.
Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal Disease Models & Mechanisms.
Start-up company ImmuVen and the University of Illinois Urbana-Champaign have entered into a license agreement under which ImmuVen will develop modified T cell receptor proteins for the purpose of treating cancer and methicillin-resistant Staphylococcus aureus.
› Verified 8 days ago
Carrie L Dul, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236 Phone: 313-884-5522 Fax: 313-884-5521 | |
Mamta Sharma, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236 Phone: 313-343-7280 Fax: 313-343-7921 | |
Ayad M. Al-katib, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 19229 Mack Ave, Suite 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 | |
Dr. Ashish Bhargava, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave Ste 333, Grosse Pointe Woods, MI 48236 Phone: 313-343-7280 Fax: 313-343-7921 | |
Dr. Ronald D Hertz, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236 Phone: 313-343-3749 Fax: 313-343-7921 | |
Thomas Joseph Loss, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 19299 Mack Ave Ste 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 | |
Zyad Kafri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19229 Mack Ave, Suite 23, Grosse Pointe Woods, MI 48236 Phone: 313-647-3245 Fax: 313-647-3244 |